Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-27

Clinical Trial Update: Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial of locoregionally advanced, resectable esophageal cancer evaluated the combination of radiation therapy with pemetrexed disodium and carboplatin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Esophageal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-03-27